360 ONE Asset acquires stake in OneSource
OneSource is a player in biologics, drug-device combinations, complex injectables, and soft gelatin capsules
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pharma market
S1P receptor modulators face uncertain future in Crohn’s disease amid trial setbacks
GlobalData’s Ulcerative Colitis Market Forecast expects Zeposia to have sales of $374.2 million worldwide in 2031, compared to…
Navigating the changing pharma landscape with innovation
Shelja Jose Kuruvilla, Head – Knowledge and Research, Vector Consulting Group underscores that the Indian pharma industry faces…
Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise…
Dr Reddy’s Laboratories, Emcure Pharma, Hetero Drugs and Mylan Labs (a subsidiary of Viatris), are among the six companies that…
Revenues to increase by 9-11 % for Indian pharma companies in FY2025: ICRA
Revenues estimated to increase by 9-11 per cent from the US market, and 7-9 per cent each from the European and the domestic…
Pharma sector set for 8-10 per cent revenue growth this fiscal
The resultant improvement in operating leverage along with easing pricing pressure in the US generics market will improve…
Lupin launches Mirabegron Extended-Release Tablets in the US
Mirabegron Extended-Release Tablets, 50 mg had estimated annual sales of $ 1,600 million in the US (IQVIA MAT July 2024)
Gilead’s Livdelzi wins FDA approval, can challenge Ocaliva dominance in primary biliary cholangitis…
The approval could present a major challenge to Ocaliva (obeticholic acid), which was until recently the sole approved drug for…
Organon, Lilly expand migraine commercialisation agreement to 11 additional markets
Under the terms of the agreement, Organon will become the sole distributor and promoter of Emgality in the following additional…
Industry reports 88 deals worth $11.1B in July 2024: GlobalData
The lifesciences sector also reported 73 VC deals worth $2.5 billion